Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Lexaria Bioscience (LEXX) Other Gross PP&E Adjustments (2017 - 2026)

Lexaria Bioscience's Other Gross PP&E Adjustments history spans 10 years, with the latest figure at $704954.0 for Q1 2026.

  • Quarterly results put Other Gross PP&E Adjustments at $704954.0 for Q1 2026, up 8.25% from a year ago — trailing twelve months through Feb 2026 was $704954.0 (up 8.25% YoY), and the annual figure for FY2025 was $665510.0, up 11.95%.
  • Other Gross PP&E Adjustments for Q1 2026 was $704954.0 at Lexaria Bioscience, up from $697487.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $704954.0 in Q1 2026 to a low of -$737903.0 in Q4 2022.
  • The 5-year median for Other Gross PP&E Adjustments is -$128025.0 (2024), against an average of $44104.2.
  • The sharpest move saw Other Gross PP&E Adjustments tumbled 909.18% in 2023, then surged 644.81% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at -$737903.0 in 2022, then skyrocketed by 78.78% to -$156565.0 in 2023, then increased by 18.23% to -$128025.0 in 2024, then surged by 644.81% to $697487.0 in 2025, then increased by 1.07% to $704954.0 in 2026.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $704954.0, $697487.0, and $665510.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.